FDA refuses Acorda NDA for Parkinson’s drug candidate because of manufacturing issues – FiercePharma


FiercePharma
FDA refuses Acorda NDA for Parkinson’s drug candidate because of manufacturing issues
FiercePharma
The company said the FDA has two issues with its NDA, saying there were questions about when its manufacturing site would be ready for a preapproval inspection and over its drug master production records. Acorda said the FDA wanted some other info as …

and more >>

Source: manufacturing – Google News

Sharing information is key – Manufacturing Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd